In mammalian cells, the splicing machinery deposits the exon junction complex (EJC) on mRNA splice junctions. Two studies in this issue now link the EJC to different aspects of translational control. Ma et al. (2008) show that the EJC activates translation downstream of the mTOR signaling pathway, whereas Isken et al. (2008) establish that translation is repressed by partners of the EJC that are implicated in nonsense mediated decay (NMD).
A eukaryotic messenger RNA (mRNA) contains not only a complete open reading frame to serve as a template for protein synthesis, but also information that regulates its export from the nucleus, subcellular localization, translation, and stability. Much of this information is carried by the proteins bound to the mRNA that comprise mRNA-protein (mRNP) particles (Moore, 2005) . However, the acquisition of these trans-acting factors is not simply attributable to the primary sequence of the transcript. The composition of pre-mRNP particles is highly dynamic and evolves at each step of its processing, including pre-mRNA transcription, polyadenylation, splicing, and export. One of the important challenges for understanding the regulation of gene expression in eukaryotes is determining how the history of an mRNP in the nucleus affects its function in the cytoplasm and the amount of the corresponding protein that is produced.
One hint that the nuclear history of an mRNA affects its fate in the cytoplasm comes from the analysis of nonsense mediated decay (NMD) in mammalian cells (reviewed in Chang et al., 2007; Conti and Izaurralde, 2005) . NMD is a process by which mRNAs carrying premature stop codons (which may encode deleterious proteins) are selectively recognized and destroyed. In mammalian cells, stop codons must be located at least 50 nucleotides upstream of the 3′ splice junction to be recognized as premature. Strikingly, this finding indicated that mRNA decay in the cytoplasm was somehow controlled by an event occurring in the nucleus. A molecular explanation for these observations was provided by the identification of the exon junction complex (EJC) (Le Hir et al., 2000) .
In mammalian cells, the EJC is assembled concomitantly with splicing and binds tightly to a newly formed mRNA at a region 24 nucleotides upstream of splice junctions. The EJC is transported with the mature mRNA to the cytoplasm and remains associated with the mRNP until the mRNA is translated. Although the core of the EJC remains unchanged during mRNP maturation, peripheral proteins associate and dissociate throughout the mRNP's journey in the cell. The EJC is involved in various cellular processes, including nucleocytoplasmic mRNA export, subcellular localization, quality control, and translation (Giorgi and Moore, 2007; Tange et al., 2004) . Two reports in this issue, by Ma et al. (2008) and Isken et al. (2008) , reveal new insights into mechanisms by which the EJC and its associated proteins activate or repress translation.
mTOR Signaling and the EJC The TOR signaling pathway plays a major role in the regulation of cell growth. TOR activity is under the control of a variety of external cellular cues ranging from amino acid concentrations to hormones through an intricate cascade of intracellular signaling pathways (Bhaskar and Hay, 2007) . TOR signals to several cellular machineries, including the translation initiation apparatus via the S6 kinase (S6K) (Mamane et al., 2006) .
In eukaryotic cells, recognition of the mRNA cap, which involves the cap-binding complex (CBC) or the translation initiation factor eIF4E, is a key step in translation as it ensures that only intact mRNAs are translated. The CBC interacts with the cap of newly made mRNAs in the nucleus and promotes their translation in the cytoplasm in the so-called pioneer round of translation (Ishigaki et al., 2001) . Studies in mammalian cells provided evidence that recognition of premature translation termination codons (PTC) and NMD occur during the first translation event. Building on these observations, Blenis and colleagues (Ma et al., 2008) tested whether the mammalian TOR (mTOR) pathway would affect the phosphorylation of proteins specifically involved in the pioneer round of translation. An examination of the proteins that coprecipitate with the CBC for the presence of possible phosphorylated S6K targets indicated that several unidentified factors present during the pioneer round of translation are also substrates of the mTOR pathway. Moreover, mTOR and one of the two mammalian S6 kinases (S6K1) were specifically found to associate with these factors. These data reveal that the mTOR pathway and translation of freshly exported mRNAs may be interconnected, prompting the search for factors that physically link these two processes. A candidate approach indicated that SKAR (S6K1 Aly/REF-like target), a previously known S6K1 substrate (Richardson et al., 2004) , mediates the recruitment of S6K1 to target mRNPs. SKAR has an RNA-binding domain and the ability to shuttle between the nucleus and the cytoplasm-two features consistent with a role in relaying TOR/S6K signals to EJCs at the Heart of Translational Control Overall, these data led Blenis and coworkers to propose that the mTOR pathway contributes to translation through the SKAR-mediated recruitment of S6K1 to newly spliced mRNAs ( Figure 1 ). Although previous work has shown that the EJC affects translational efficiency Wiegand et al., 2003; Diem et al., 2007) , the study of Ma et al. (2008) provides a new mechanistic description for how this could occur. The authors also provide evidence for the existence of several factors phosphorylated by S6K1 in initiation complexes bound to the CBC factor. It will thus be of interest to determine whether S6K1 recruitment is sufficient to account for the enhanced translation efficiency mediated by the EJC or whether other factors are participating in this process.
An interesting feature of the EJC is that it distinguishes newly formed mRNAs from older templates that have already been translated. Hence, an important aspect of the observations reported by Blenis and collaborators is that the mTOR/S6K1 pathway specifically targets newly made mRNAs. Through this mechanism, cells further stimulate the production of proteins from genes that have been recently turned on. Overall such stimulation shortens the lag time between transcriptional induction and downstream biological effects. This is particularly important in eukaryotes, where production of translatable mRNAs is often a lengthy process. Indeed, pre-mRNA synthesis often takes dozens of minutes, but may in extreme cases last for several hours, and is usually followed by complex mRNA processing steps. This timeconsuming process of building an mRNA could prevent cells from responding rapidly to external stimuli. The targeted stimulation of translation of newly made mRNAs through the EJC, SKAR, and mTOR/ S6K1 pathway partly counterbalances the slow rate of mRNA production. Given that the first round of translation removes EJCs, this effect may be short lived and restricted to a small number of translation initiation events, unless substrates of S6K1 that favor translation initiation were to remain associated with the mRNP following EJC dissociation.
The discovery that SKAR associates with the EJC is surprising. Indeed, previous studies involving the purification of mRNPs spliced in vitro failed to identify SKAR (Merz et al., 2007) . A possible explanation for this is that SKAR might join some, but not all, EJCs. Given the presence of an RNA-binding domain in SKAR, an intriguing possibility is that SKAR may preferentially associate with a specific subset of mRNAs (such as those that are the primary targets of regulation by S6K).
The Ma et al. (2008) study provides unanticipated insights into the mechanism by which the EJC promotes translational enhancement. Thus, it may seem ironic that this step forward occurs at the same time as another report showing that EJC partners have a role in translational repression during the NMD process. Yet, these findings are not contradictory but instead underscore the central and unexpected role of the EJC in translational control.
Upf1 Activation Represses Translation during NMD NMD recognizes and triggers the degradation of mRNAs bearing a premature translation termination codon (PTC) (Chang et al., 2007; Conti and Izaurralde, 2005) . NMD is important for ridding cells of PTC-containing mRNAs that arise from DNA mutation, unproductive DNA rearrangements, or incorrect (A) Splicing of a normal pre-mRNA in the nucleus generates a functional mRNA containing two exon junction complexes (EJCs). SKAR joins one of these two EJCs before export of the mRNA to the cytoplasm. It is currently unclear whether SKAR joins all or only a subset of all EJCs (as depicted here). In the cytoplasm, S6K1 joins SKAR and stimulates translation upon activation by mTOR, at least during the pioneer round of translation. (B) Transcription of a pre-mRNA containing a premature termination codon (PTC) leads to the generation of a nonfunctional mRNA bound by two EJCs. Following its transport to the cytoplasm, the first translational event leads to the ribosome terminating at the PTC. The SURF complex (containing unphosphorylated Upf1), which is assembled on this ribosome, then interacts with Upf2 and Upf3 that have been recruited on a downstream EJC. This induces Upf1 phosphorylation, which inhibits further rounds of translation initiation through interaction with eIF3 before or concomitant with the induction of mRNA decay by the NMD pathway. mRNA processing. In addition, NMD regulates the expression of a significant fraction of normal genes in several eukaryotic species. In eukaryotes, the conserved protein core of the NMD machinery is composed of the Upf1, Upf2, and Upf3 proteins. The central effector is Upf1, an RNA helicase that connects translation termination and assembly of the surveillance complex. In most multicellular organisms, cycles of phosphorylation and dephosphorylation of Upf1 are crucial for NMD. These cycles are mediated by SMG1, SMG5, SMG6, and SMG7. PTCcontaining mRNAs marked by the Upf complex are eventually degraded in P bodies by the same factors that are involved in general mRNA degradation.
Distinguishing PTCs from normal termination codons is an essential step of NMD that is only partially understood. The prevailing model is that in addition to the recognition of the stop codon by the translational machinery, another signal downstream of the stop codon is required to define it as premature. In the budding yeast Saccharomyces cerevisiae, the fruit fly Drosophila melanogaster, and the worm Caenorhabditis elegans, this signal might originate from the abnormally long 3′UTR generated by the PTC, although the mechanism remains to be clarified (Amrani et al., 2004) . For most mRNAs in mammals, PTCs have been shown to elicit NMD when positioned more than 50 nucleotides upstream of an exon-exon boundary. With a few exceptions, most normal termination codons are located downstream of the last intron and most PTC-containing genes that lack introns are immune to NMD. By first recruiting Upf3 and then Upf2, the EJC communicates intron positions to the NMD machinery.
Our current understanding indicates that triggering of NMD may follow a stepwise pathway. (1) During the first round of translation, the ribosome terminating on a PTC recruits Upf1 via its interaction with the release factors eRF1 and eRF3, and SMG1 to form the SURF (SMG1-Upf1-eRF1-eRF3) complex (Kashima et al., 2006) . (2) This transient SURF complex bridges the ribosome with the downstream EJC associated with Upf3 and Upf2. (3) The interaction of Upf1 and SMG1 with Upf2 bound to the EJC triggers the phosphorylation of Upf1 by SMG1. (4) The resulting complex, which contains the EJC, Upf3, Upf2, and phosphorylated Upf1, represents the key signal to induce degradation of the mRNA.
In their new study, Isken and colleagues (2008) provide molecular insights into a new function of phosphorylated Upf1 during the last steps of NMD. In addition to triggering degradation of PTC-containing mRNAs, the authors show that Upf1 decreases translation initiation of its partner mRNA. Indeed, downregulation of Upf1 by a small interfering RNA leads to a marked increase in the translation efficiency of mRNA reporters encoding luciferase. A similar effect is observed when translation initiation of a luciferase reporter is driven by the internal ribosomal entry site (IRES) of the Hepatitis C virus. In contrast to classical 5′ cap-dependent translation initiation, this IRES directly binds to the ribosomal 40S subunit with no need for the initiation factors recruited by the cap structure. This is converted in active 80S ribosomes in a reaction requiring the initiation factors eIF2-initiator tRNA and eIF3. The authors made the interesting observation that downregulation of Upf1 has almost no effect on luciferase translation when it is dependent on the IRES of the cricket paralysis virus (CrPV), which undergoes IRES-mediated translation by a mechanism independent of translation initiation factors. This result strongly argues that Upf1 has a previously unsuspected function as an inhibitor of translation initiation. This function of Upf1 seems essential for the process of NMD because a well-known NMD target (β-globin PTC-39 mRNA) is not subjected to NMD when its translation is initiated by the CrPV IRES. Although unlikely, an alternative interpretation of this result is that the peculiar mode of translation initiation driven by the CrVP IRES prevents efficient joining of Upf1 to the translation termination complex.
Phosphorylation of Upf1 constitutes an important step during the process of NMD that precedes mRNA degradation. Isken and colleagues examined the role of Upf1 phophorylation and showed that it inhibits translation initiation. One could imagine that the inhibition of translation initiation by phosphorylated Upf1 is indirect and a consequence of activation of mRNA decay by NMD, which removes mRNA extremities including the 5′ cap structure and the 3′ poly(A) tail. Indeed, these structures are associated with factors important for translation initiation including the CBC during the pioneer round of translation or the binding of the eIF4F complex to the cap structure, and the association of poly(A)-binding protein with the poly(A) tail. However, their results suggest that Upf1 mostly likely acts directly on the initiation phase of translation. First, they show that the components of the eIF3 complex are coimmunoprecipitated by Upf1 and that this interaction is enhanced when Upf1 is hyperphosphorylated. In addition, far-western assays indicate that Upf1 interacts with the large subunit of eIF3, eIF3a. Second, they employed an in vitro strategy using rabbit reticulocyte lysates that recapitulates translation but not mRNA degradation in vitro. By monitoring the assembly of ribosomal subunits on a synthetic mRNA substrate by sucrose-gradient sedimentation, the authors observed that hyperphosphorylated Upf1 does not affect the recruitment of the 40S/initiator tRNA complex onto the mRNA. However, hyperphosphorylated Upf1 (but not wild-type Upf1) precludes the conversion of the 40S/initiator tRNA complex into 80S ribosomes that are competent for translation.
In light of their observations, the authors integrate the newly proposed function of Upf1 into the current model of NMD (Figure 1) . During the first round of translation in the case of premature translation termination, Upf1 is recruited to a ribosome via the assembly of the SURF complex. Then, Upf1 and SMG1 associate with the EJC located downstream, triggering phosphorylation of Upf1 by SMG1. At this stage, phosphorylated Upf1 not only allows the recruitment of mRNA decay factors (by a mechanism that remains unclear), but also makes contact with eIF3, preventing the initiation of additional rounds of translation. Interestingly, recent results indicate that eIF3 is involved in ribosome recycling after translation termination (Pisarev et al., 2007) , suggesting that Upf1 and eIF3 may be properly positioned during termination to interact and block further rounds of translation. This mechanism would prevent the synthesis of truncated proteins. Furthermore, this process may release the mRNP particle from the translation machinery, allowing access for the decay machinery and/or its transport to a P body for degradation. This dual function of Upf1 is consistent with the notion that the ultimate purpose of NMD is to prevent aberrant protein synthesis more than it is a means to shorten the half-life of mRNA substrates.
However, a puzzling result reported by Isken et al. (2008) suggests that the situation may be more complex. The authors observed that the downregulation of Upf2 or a particular form of Upf3, Upf3b (also known as Upf3X), by siRNA treatment prevented NMD but did not affect translation. This observation suggests that different levels of phosphorylated Upf1 may be necessary to sustain translation inhibition and mRNA decay. One could envisage that translation inhibition by phosphorylated Upf1 represents a pathway that is independent of the NMD process. Further studies will be necessary to determine the connection between these two events. Along this line, it will be important to test whether Upf1 also affects translation initiation in other organisms, especially in yeast where evidence suggests that translation is inhibited during NMD (Muhlrad and Parker, 1999) . A better understanding of the signal(s) inducing productive Upf1 recruitment will be essential to decipher its downstream mode of action in mRNA decay and/or translation.
Perspectives
The compartmentalization of mRNA production and protein translation in eukaryotes most likely increases the efficiency of these processes, although it makes gene expression slower in eukaryotes when compared to prokaryotic cells. The physical decoupling of mRNA production from translation might also make it difficult to distinguish newly made mRNAs from older ones. Yet, this is not the case, at least not in mammalian cells where the EJC provides a molecular stamp with which cells are able differentiate newly made mRNAs from older transcripts. The platform established by the core of the EJC functions in several posttranscriptional regulatory steps including mRNA decay, localization, and translation through interaction with specific factors. It is likely that additional new functions of the EJC will be discovered. Interestingly, most functions of the EJC appear to be directly or indirectly connected to translational activation or repression. For example, mRNA localization needs to be tightly coordinated with translational control to prevent the production of proteins at unwanted places in the cell. Future studies will undoubtedly reveal how enhancement or repression of translation involving the EJC may target different mRNAs in the same cell. Interestingly, the core EJC protein eIF4AIII is highly similar to the translation initiation factor eIF4A and may be an evolutionary relic indicative of the tight functional relationship between the EJC and translation. Surprisingly, despite the clear advantages provided by EJCs in the control of gene expression, conservation of the subunits of this complex appears to be limited to metazoans. Nevertheless, processes such as NMD, mRNA localization, and translational enhancement of spliced mRNAs also occur in organisms in which EJCs are not supposed to be present, as has been reported for the yeast Saccharomyces cerevisiae (Juneau et al., 2006) . It will be of interest to identify other features of newly made mRNAs that promote their recognition by key cellular machineries.
